[1]
“In Silico ADME–Toxicity Profiling of 3,4-dithia-1-azabicyclo[3.2.0]heptan-7-one: Integrating Drug-Likeness, Pharmacokinetics, and Prediction Confidence”, JMHS, vol. 5, no. 1, pp. 61–80, Sep. 2026, doi: 10.51317/jmhs.v5i1.1194.